for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Agenus Receives Fast Track Designation For Balstilimab In Advanced Cervical Cancer

April 7 (Reuters) - Agenus Inc:

* AGENUS RECEIVES FAST TRACK DESIGNATION FOR BALSTILIMAB IN ADVANCED CERVICAL CANCER

* EXPECTS TO FILE 2 BLAS THIS YEAR FOR ACCELERATED APPROVAL OF BALSTILIMAB IN METASTATIC CERVICAL CANCER Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up